DW Healthcare Partners (DWHP) has acquired Hill Top Research, Inc. DWHP’s acquisition will allow Hill Top to expand capacity, add new technical capabilities, and provide additional resources for growth. The acquisition also allows funds to be allocated for growth initiatives, including further expansion into the personal care, oral care, and pharmaceutical services markets and possible industry acquisitions. Additionally, Jim Pearce, Hill Top’s chief executive officer for the past 26 years, is retiring effective with this transaction. Joel Ivers, who served as Hill Top’s chief operating officer, has been named chief executive officer.

“We are very excited by DWHP’s acquisition, and we look forward to many years of growth and opportunity for all Hill Top associates,” said Joel Ivers. “This investment enhances our ability to continue to offer unparalleled clinical research expertise and robust subject recruiting at our multiple and diverse locations throughout North America. In addition, we can continue to invest in providing high quality studies for our clients.”

“We at DWHP are pleased to partner with Hill Top,” said vice president, Doug Schillinger. “Hill Top has unmatched experience in the markets they serve, and is recognized as a first-class service provider.” The new company, called Hill Top Acquisition Corp., will do business as Hill Top Research.